Team
Learn more about our 2024 Scientific Steering Committee, Scientific Advisory Board,
our Executive Committee and Core Team Support.
2024 Scientific Steering Committee
-
Vadim Gladyshev, PhD
HARVARD UNIVERSITY
Dr. Gladyshev is a Professor of Medicine at Harvard Medical School and Director of Redox Medicine at Brigham & Women's Hospital.
Relevant expertise:
Aging clocks and other biomarkers of biological age. -
Andrea Maier, MD
NATIONAL UNIVERSITY OF SINGAPORE
Dr. Maier is a Professor in Medicine and Healthy Ageing and the Co-Director of Center for Healthy Longevity at the National University of Singapore and a Fellow of the Royal Australasian College of Physicians.
Relevant expertise:
Healthy aging and longevity biomarkers. -
Vittorio Sebastiano, PhD
STANFORD UNIVERSITY
Dr. Sebastiano is an Associate Professor in the Department of Obstetrics & Gynecology at Stanford School of Medicine and the Co-Founder of Turn Biotechnologies.
Relevant expertise:
Biomarkers of cellular rejuvenation. -
Michael Snyder, PhD
STANFORD UNIVERSITY
Dr. Snyder is the Chair of the Department of Genetics at Stanford School of Medicine and the Director of the Center for Genomics and Personalized Medicine.
Relevant expertise:
Longitudinal biomarkers of aging and Multiomic Ageotyping. -
Eric Verdin, MD
BUCK INSTITUTE FOR RESEARCH ON AGING
Dr. Verdin is President and Chief Executive Officer of the Buck Institute for Research on Aging, as well as Professor of Medicine at University of California, San Francisco.
Relevant expertise:
Biomarkers of immune aging.
Scientific Advisory Board
-
Nir Barzilai, MD
AMERICAN FEDERATION FOR AGING RESEARCH
Director of the Einstein Institute of Aging Research, Board Member and Scientific Director of the American Federation of Aging Research, as well as a number of other positions.
Relevant experience:
Translational geroscience, healthy aging, and longevity biomarkers. -
Daniel Belsky, PhD
COLUMBIA UNIVERSITY
Dr. Belsky is an Associate Professor of Epidemiology in the Robert N. Butler Columbia Aging Center. He has published extensively on aging and health in scientific journals and is recognized for developing the Pace of Aging method and the DunedinPoAm and DunedinPACE aging clocks.Relevant experience:
Aging clocks and biomarkers of aging -
Steve Cummings, MD
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
Dr. Cummings is an internationally recognized expert on the epidemiology of osteoporosis, women's health, and aging.
Relevant experience:
Healthy aging and longevity biomarkers. -
Luigi Ferrucci, MD
NATIONAL INSTITUTE ON AGING
Dr. Ferrucci is a geriatrician and an epidemiologist who conducts research on the biological and phenotypical pathways leading to progressive physical and cognitive decline in older persons.
Relevant experience:
Healthy aging and longevity biomarkers. -
David Furman, PhD
BUCK INSTITUTE
Dr. Furman is an Associate Professor and the Director of the Bioinformatics Core at the Buck Institute for Research on Aging and Head of the Stanford 1000 Immunomes Project at the Stanford School of Medicine, focusing on inflammaging and translational human interventions for age related decline in intrinsic capacity.
Relevant experience:
Longevity biomarkers, aging clocks, functional aging, translational geroscience -
Steve Horvath, PhD
ALTOS LABS
Dr. Horvath is a Principal Investigator at the Altos Labs Cambridge Institute of Science. He was previously a Professor of Human Genetics and Biostatistics at the University of California, Los Angeles.
Relevant experience:
Aging clocks and other biomarkers of biological age. -
Jamie Justice, PhD
XPRIZE HEALTHSPAN
Executive Director of XPRIZE Healthspan and Adjunct Professor in Internal Medicine - Gerontology and Geriatric Medicine at Wake Forest University School of Medicine.
Relevant experience:
Translational geroscience and Open Innnovation. -
Brian Kennedy, PhD
NATIONAL UNIVERSITY OF SINGAPORE
Dr. Kennedy is Director at the Centre for Healthy Longevity as well as a Professor at the Departments of Biochemistry and Physiology at the National University of Singapore.
Relevant experience:
Healthy aging and longevity biomarkers. -
Viviana Perez, PhD
HEVOLUTION
Viviana Perez, PhD is a scientist with a focus on the biology of aging and geroscience. She was formerly with the US’ National Institutes of Health (NIH) and National Institute on Aging (NIA).
Relevant experience:
Biology of aging and geroscience -
Tony Wyss-Coray, PhD
STANFORD UNIVERSITY
Tony Wyss-Coray is the D.H. Chen Distinguished Professor of Neurology and Neurological Sciences and the Director of the Phil and Penny Knight Initiative for Brain Resilience at Stanford University.
Relevant experience:
Brain aging and neurodegeneration
2024 Executive Committee
-
Mahdi Moqri, PhD, MBA
STANFORD & HARVARD UNIVERSITIES
Dr. Moqri is a faculty member at Harvard University and the co-Director of the Consortium.
Relevant expertise:
Biomarkers of aging and rejuvenation and their validation. -
Jesse Poganik, PhD
HARVARD UNIVERSITY
Dr. Poganik is an Instructor in Medicine at Brigham and Women's Hospital and Harvard Medical School and the co-Director of the Consortium.
Relevant expertise:
Epigenetic clocks of aging in human and model animals. -
Dane Gobel
METHUSELAH FOUNDATION
Dane Gobel is the Co-Founder and Program Director for the Methuselah Foundation.
Relevant expertise:
Biotech non-profit management, open innovation. -
Chiara Herzog, PhD
UNIVERSITY OF INNSBRUCK
Dr. Herzog is a researcher and lecturer at the University of Innsbruck.
Relevant expertise:
Translational human studies and epigenetic and multi-omic biomarkers of cancer and aging. -
Allison Duettmann
FORESIGHT INSTITUTE
Allison Duettmann is the President and CEO of Foresight Institute.
Relevant expertise:
Advanced biotech, nanotech, computing for the long-term benefit of life. -
Andrea Cipriano, PhD
STANFORD UNIVERSITY
Dr. Cipriano is a Faculty Instructor at Stanford University School of Medicine as well as a volunteer for the Biomarkers of Aging Consortium.
Relevant experience:
Biomarkers of aging R&D, Conference Planning, Project Management
Core Team
-
Luisa Georgiana Bâcă, PhD, MD
NATIONAL INSTITUTE ON AGING
Dr. Bâcă is a Physician Scientist and Postdoctoral Fellow at the Laboratory of Cardiovascular Science, National Institute on Aging, NIH.
Relevant experience:
Clinical translation of biomarkers of aging and age-related diseases. -
Nicholas C. Fiorenza, MSc
METHUSELAH FOUNDATION
Nicholas manages Biotech Operations for the Methuselah Foundation and Biomarkers of Aging Consortium.
Relevant experience:
Life sciences entrepreneurship, business development, community building, conferences and events, marketing, project management -
Ludger Goeminne, PhD
HARVARD UNIVERSITY
Dr. Goeminne is a post-doctoral researcher at Harvard Medical School and volunteer for the Biomarkers of Aging Consortium.
Relevant experience:
Proteomic and organ-specific biomarkers of aging, Conference planning -
Seth Paulson
METHUSELAH FOUNDATION
Seth is a seasoned software developer leading the development of the Consortium’s Biolearn program.
Relevant experience:
Software development, bioinformatics. -
Albert Ying, MSc
HARVARD MEDICAL SCHOOL
Albert is a Ph.D. candidate at Harvard University and co-leading the development of the Consortium’s Biolearn program and BoA Competition.
Relevant experience:
Systems biology of aging, machine learning.